Khan Raysa, Boonseng Sarote, Kemmitt Paul D, Felix Robert, Coles Simon J, Tizzard Graham J, Williams Gareth, Simmonds Olivia, Harvey Jessica-Lily, Atack John, Cox Hazel, Spencer John
Department of Chemistry School of Life Sciences University of Sussex Falmer BN1 9QJ UK.
Oncology AstraZeneca 310 Cambridge Science Park Milton Road Cambridge CB4 0WG UK.
Adv Synth Catal. 2017 Sep 18;359(18):3261-3269. doi: 10.1002/adsc.201700626. Epub 2017 Aug 2.
5-Phenyl-1,3-dihydro--1,4-benzodiazepin-2-ones react under palladium- and visible light photoredox catalysis, in refluxing methanol, with aryldiazonium salts to afford the respective 5-(2-arylphenyl) analogues. With 2- or 4-fluorobenzenediazonium derivatives, both fluoroaryl- and methoxyaryl- products were obtained, the latter resulting from a SAr on the fluorobenzenediazonium salt ("nuisance effect"). A computational DFT analysis of the palladium-catalysed and the palladium/ruthenium-photocalysed mechanism for the functionalization of benzodiazepines indicated that, in the presence of the photocatalyst, the reaction proceeds via a low-energy SET pathway avoiding the high-energy oxidative addition step in the palladium-only catalysed reaction pathway.
5-苯基-1,3-二氢-1,4-苯并二氮杂卓-2-酮在钯和可见光光氧化还原催化下,于回流甲醇中与芳基重氮盐反应,生成相应的5-(2-芳基苯基)类似物。与2-氟苯重氮或4-氟苯重氮衍生物反应时,得到了氟芳基产物和甲氧基芳基产物,后者是由氟苯重氮盐上的亲核芳香取代反应(“干扰效应”)产生的。对苯并二氮杂卓官能化的钯催化和钯/钌光催化机理进行的计算密度泛函理论(DFT)分析表明,在光催化剂存在下,反应通过低能量的单电子转移(SET)途径进行,避免了仅钯催化反应途径中高能量的氧化加成步骤。